Claritev Total Liabilities 2019-2025 | CTEV

Claritev total liabilities from 2019 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
Claritev Annual Total Liabilities
(Millions of US $)
2024 $5,067
2023 $5,256
2022 $5,581
2021 $5,876
2020 $5,726
2019 $6,375
2018 $0
Claritev Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $5,070
2024-12-31 $5,067
2024-09-30 $5,112
2024-06-30 $5,139
2024-03-31 $5,196
2023-12-31 $5,256
2023-09-30 $5,308
2023-06-30 $5,368
2023-03-31 $5,427
2022-12-31 $5,581
2022-09-30 $5,755
2022-06-30 $5,807
2022-03-31 $5,884
2021-12-31 $5,876
2021-09-30 $5,923
2021-06-30 $6,004
2021-03-31 $5,979
2020-12-31 $5,726
2020-09-30 $49
2020-06-30 $40
2020-03-31 $39
2019-12-31
2018-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.620B $0.931B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.108B 58.66
Hims & Hers Health (HIMS) United States $12.792B 132.91
Tempus AI (TEM) United States $12.331B 0.00
IRhythm Technologies (IRTC) United States $4.644B 0.00
Inspire Medical Systems (INSP) United States $3.793B 59.27
Privia Health (PRVA) United States $2.768B 189.17
Hinge Health (HNGE) United States $2.732B 0.00
Enovis (ENOV) United States $1.845B 10.28
Schrodinger (SDGR) United States $1.676B 0.00
Phreesia (PHR) United States $1.584B 0.00
Clover Health Investments (CLOV) United States $1.491B 0.00
Omnicell (OMCL) United States $1.403B 24.74
Azenta (AZTA) United States $1.392B 64.70
10x Genomics (TXG) United States $1.303B 0.00
Fulgent Genetics (FLGT) United States $0.639B 0.00
Butterfly Network (BFLY) United States $0.603B 0.00
Talkspace (TALK) United States $0.502B 150.00
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.399B 0.00
Outset Medical (OM) United States $0.359B 0.00
TruBridge (TBRG) United States $0.357B 792.33
Health Catalyst (HCAT) United States $0.277B 0.00
Nyxoah SA (NYXH) Belgium $0.258B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.193B 0.00
KORU Medical Systems (KRMD) United States $0.148B 0.00
Pulmonx (LUNG) United States $0.126B 0.00
EUDA Health Holdings (EUDA) Singapore $0.126B 0.00
American Well (AMWL) United States $0.112B 0.00
MDxHealth SA (MDXH) Belgium $0.101B 0.00
CareCloud (CCLD) United States $0.091B 3.48
111 (YI) China $0.071B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Zhongchao (ZCMD) China $0.033B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00